» Articles » PMID: 17419091

Sporadic Colorectal Cancer and Individual Susceptibility: a Review of the Association Studies Investigating the Role of DNA Repair Genetic Polymorphisms

Overview
Journal Mutat Res
Publisher Elsevier
Specialty Genetics
Date 2007 Apr 10
PMID 17419091
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

Mutations in one of the DNA repair genes are one of the most common reasons for cancer, and it may be assumed that the individual genetic background modulating the DNA repair capacity may affect the susceptibility to cancer. Numerous polymorphisms (mainly SNPs) have been identified for DNA repair genes, although their functional outcome and phenotypic effect is often unknown. The aim of the present review is to evaluate the studies investigating a possible influence of DNA repair polymorphisms in the risk of sporadic colorectal cancer and/or adenoma. Overall, no relevant common findings emerge among the studies, except for some statistically significant associations between polymorphisms in the XRCC1 and XPD genes, mainly for colorectal adenoma risk. Other individual associations remain to be confirmed. This inconclusive data may suggest that the modulation of cancer risk depends not only on a single gene/SNP, but also on a joint effect of multiple polymorphisms (or haplotypes) within different genes or pathways, in close interaction with environmental factors. The relevance of many low-penetrance genes in cancer susceptibility is supposed to be very subtle. Several reviewed association studies revealed weaknesses in their design. However, there has been a progressive improvement over the years in aspects such as simultaneous genotyping and combined analyses of different polymorphisms in larger numbers of patients and controls, as well as stratification of results by ethnicity, gender, and tumor localization. This gained experience shows that only carefully designed studies of a sufficient statistical power may resolve the relationships between polymorphisms and colorectal cancer risk.

Citing Articles

R194W and R399Q Polymorphisms and Colorectal Cancer Risk in a Northeastern Mexican Population.

Meza-Espinoza J, Peralta-Leal V, Duran-Gonzalez J, Macias-Gomez N, Bocanegra-Alonso A, Leal-Ugarte E Genet Res (Camb). 2023; 2023:5565646.

PMID: 37829155 PMC: 10567464. DOI: 10.1155/2023/5565646.


-miRNA-4647 axis in colorectal cancer: Prospects to identifications of risk factors and clinical outcomes.

Sojka L, Opattova A, Bartu L, Horak J, Korenkova V, Novosadova V Oncol Lett. 2023; 25(2):72.

PMID: 36688110 PMC: 9843305. DOI: 10.3892/ol.2022.13658.


Possible Mechanisms of Subsequent Neoplasia Development in Childhood Cancer Survivors: A Review.

Kruseova J, Vicha A, Feriancikova B, Eckschlager T Cancers (Basel). 2021; 13(20).

PMID: 34680213 PMC: 8533890. DOI: 10.3390/cancers13205064.


A Bayesian hierarchical model to estimate DNA methylation conservation in colorectal tumors.

Murgas K, Ma Y, Shahidi L, Mukherjee S, Allen A, Shibata D Bioinformatics. 2021; 38(1):22-29.

PMID: 34487148 PMC: 10060692. DOI: 10.1093/bioinformatics/btab637.


The Role of Formyl Peptide Receptor 1 Gene Polymorphisms in Human Colorectal Cancer.

Li S, Yu Y, Zhang Y, Sun Y, Li X, Su N J Cancer. 2020; 11(12):3580-3587.

PMID: 32284754 PMC: 7150440. DOI: 10.7150/jca.36355.